Literature DB >> 16767843

Human genetics of variation in high-density lipoprotein cholesterol.

Atif Qasim1, Daniel J Rader.   

Abstract

Longitudinal population studies have confirmed plasma levels of high-density lipoprotein (HDL) cholesterol to be an important inverse coronary risk factor. Although environmental influences are known to regulate HDL cholesterol levels, genetic factors are also known to be important, and over 25 candidate genes have been proposed to be associated with variation in HDL cholesterol levels. A variety of monogenic conditions of extremely low or high HDL cholesterol has helped to delineate the physiology of HDL cholesterol metabolism in humans, which has led to the development of new therapeutic approaches to HDL cholesterol. However, most causes of genetic variation in HDL cholesterol in the general population are likely oligogenic or polygenic. We review the monogenic disorders associated with both high and low HDL cholesterol and the relevance of mutations and polymorphisms in these genes to variation in HDL cholesterol levels in the general population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767843     DOI: 10.1007/s11883-006-0074-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  75 in total

1.  Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans.

Authors:  Rector Arya; Ravindranath Duggirala; Laura Almasy; David L Rainwater; Michael C Mahaney; Shelley Cole; Thomas D Dyer; Ken Williams; Robin J Leach; James E Hixson; Jean W MacCluer; Peter O'Connell; Michael P Stern; John Blangero
Journal:  Nat Genet       Date:  2001-12-17       Impact factor: 38.330

2.  Meta-analysis of genome-wide linkage studies for quantitative lipid traits in African Americans.

Authors:  Alka Malhotra; Hilary Coon; Mary F Feitosa; Wei-Dong Li; Kari E North; R Arlen Price; Claude Bouchard; Steven C Hunt; Johanna K Wolford
Journal:  Hum Mol Genet       Date:  2005-11-21       Impact factor: 6.150

3.  Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.

Authors:  K Hirano; S Yamashita; N Nakajima; T Arai; T Maruyama; Y Yoshida; M Ishigami; N Sakai; K Kameda-Takemura; Y Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

4.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

Authors:  A Inazu; M L Brown; C B Hesler; L B Agellon; J Koizumi; K Takata; Y Maruhama; H Mabuchi; A R Tall
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

5.  Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.

Authors:  K F Kozarsky; M H Donahee; A Rigotti; S N Iqbal; E R Edelman; M Krieger
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

Review 6.  The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes.

Authors:  J A Kuivenhoven; H Pritchard; J Hill; J Frohlich; G Assmann; J Kastelein
Journal:  J Lipid Res       Date:  1997-02       Impact factor: 5.922

7.  Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism.

Authors:  Ke Ma; Mehmet Cilingiroglu; James D Otvos; Christie M Ballantyne; Ali J Marian; Lawrence Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 8.  Hepatic lipase deficiency.

Authors:  P W Connelly; R A Hegele
Journal:  Crit Rev Clin Lab Sci       Date:  1998-12       Impact factor: 6.250

9.  A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster.

Authors:  Heidi E Lilja; Aino Soro; Kati Ylitalo; Ilpo Nuotio; Jorma S A Viikari; Veikko Salomaa; Erkki Vartiainen; Marja-Riitta Taskinen; Leena Peltonen; Päivi Pajukanta
Journal:  Atherosclerosis       Date:  2002-09       Impact factor: 5.162

10.  Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects.

Authors:  N Sakai; S Yamashita; K Hirano; M Menju; T Arai; K Kobayashi; M Ishigami; Y Yoshida; T Hoshino; N Nakajima
Journal:  Atherosclerosis       Date:  1995-04-24       Impact factor: 5.162

View more
  15 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

2.  Improvements in the lifestyle of patients who have had type 1 diabetes for 50 years: an optimistic message.

Authors:  J-J Altman; C Vincent-Cassy; S Feldman-Billard
Journal:  Diabetologia       Date:  2008-11-26       Impact factor: 10.122

3.  A genome-wide linkage scan identifies multiple quantitative trait loci for HDL-cholesterol levels in families with premature CAD and MI.

Authors:  Rong Yang; Lin Li; Sara Bretschger Seidelmann; Gong-Qing Shen; Sonia Sharma; Shaoqi Rao; Kalil G Abdullah; Kenneth G Mackinlay; Robert C Elston; Qiuyun Chen; Eric J Topol; Qing Kenneth Wang
Journal:  J Lipid Res       Date:  2010-01-14       Impact factor: 5.922

4.  Familial resemblances in blood leukocyte DNA methylation levels.

Authors:  Bénédicte L Tremblay; Frédéric Guénard; Benoît Lamarche; Louis Pérusse; Marie-Claude Vohl
Journal:  Epigenetics       Date:  2016-09-09       Impact factor: 4.528

Review 5.  Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

6.  Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans.

Authors:  Roshni R Singaraja; Ian Tietjen; G Kees Hovingh; Patrick L Franchini; Chris Radomski; Kenny Wong; Margaret vanHeek; Ioannis M Stylianou; Linus Lin; Liangsu Wang; Lyndon Mitnaul; Brian Hubbard; Michael Winther; Maryanne Mattice; Annick Legendre; Robin Sherrington; John J Kastelein; Karen Akinsanya; Andrew Plump; Michael R Hayden
Journal:  J Lipid Res       Date:  2014-06-02       Impact factor: 5.922

7.  Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia.

Authors:  Mary B Engler; Clive R Pullinger; Mary J Malloy; Yanina Natanzon; Medha V Kulkarni; James Song; Celeste Eng; Jaarko Huuskonen; Christopher Rivera; Annie Poon; Matt Bensley; Amy Sehnert; Christian Zellner; John Kane; Bradley E Aouizerat
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

8.  Population-Based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels.

Authors:  Hamid Razzaghi; Stephanie A Santorico; M Ilyas Kamboh
Journal:  Front Genet       Date:  2012-06-14       Impact factor: 4.599

9.  VNN1 gene expression levels and the G-137T polymorphism are associated with HDL-C levels in Mexican prepubertal children.

Authors:  Leonor Jacobo-Albavera; Pablo I Aguayo-de la Rosa; Teresa Villarreal-Molina; Hugo Villamil-Ramírez; Paola León-Mimila; Sandra Romero-Hidalgo; Blanca E López-Contreras; Fausto Sánchez-Muñoz; Rafael Bojalil; Juan Antonio González-Barrios; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Looking beyond GWAS: allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels.

Authors:  Marco Cavalli; Gang Pan; Helena Nord; Claes Wadelius
Journal:  Lipids Health Dis       Date:  2016-01-27       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.